Siemens Healthineers AG provided earnings guidance for the year 2022. For fiscal year 2022, the company expects comparable revenue growth between 0% and 2% from fiscal year 2021. Excluding revenue from rapid COVID-19 antigen tests, the company expects comparable revenue growth between 5% and 7%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
53.68 EUR | -0.04% | -1.18% | +2.05% |
23/05 | Ailing hospitals slow down German medical technology sector | DP |
22/05 | SIEMENS HEALTHINEERS : Berenberg maintains a Buy rating | ZD |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.05% | 64.85B | |
+10.03% | 223B | |
+13.59% | 194B | |
+20.01% | 141B | |
+30.83% | 109B | |
+15.38% | 52.7B | |
+3.96% | 51.77B | |
+8.37% | 44.12B | |
+3.27% | 36.21B | |
+23.97% | 31.08B |
- Stock Market
- Equities
- SHL Stock
- News Siemens Healthineers AG
- Siemens Healthineers AG Provides Earnings Guidance for the Year 2022